Black PL - Search Results

1

Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.

Abe F, Schneider M, Black PL, Talmadge JE. Abe F, et al. Among authors: black pl. Cancer Immunol Immunother. 1989;29(4):231-6. doi: 10.1007/BF00199209. Cancer Immunol Immunother. 1989. PMID: 2752391 Free PMC article.

2

Antitumor response to recombinant murine interferon gamma correlates with enhanced immune function of organ-associated, but not recirculating cytolytic T lymphocytes and macrophages.

Black PL, Phillips H, Tribble HR, Pennington R, Schneider M, Talmadge JE. Black PL, et al. Cancer Immunol Immunother. 1993 Oct;37(5):299-306. doi: 10.1007/BF01518452. Cancer Immunol Immunother. 1993. PMID: 8402733 Free PMC article.

3

Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice.

Talmadge JE, Black PL, Pelus LM, Abe F. Talmadge JE, et al. Among authors: black pl. Biomed Pharmacother. 1990;44(2):85-91. doi: 10.1016/0753-3322(90)90109-m. Biomed Pharmacother. 1990. PMID: 2224059

4

Effect of tumor burden and route of administration on the immunotherapeutic properties of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethyl cellulose [Poly(I,C)-LC].

Black PL, Hartmann D, Pennington R, Phillips H, Schneider M, Tribble HR, Talmadge JE. Black PL, et al. Int J Immunopharmacol. 1992 Nov;14(8):1341-53. doi: 10.1016/0192-0561(92)90005-6. Int J Immunopharmacol. 1992. PMID: 1464467

5

Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice.

Talmadge JE, Pelus LM, Black PL, Abe F. Talmadge JE, et al. Among authors: black pl. Biomed Pharmacother. 1991;45(2-3):61-9. doi: 10.1016/0753-3322(91)90124-c. Biomed Pharmacother. 1991. PMID: 1912371

6

Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2.

Talmadge JE, Black PL, Tribble H, Pennington R, Bowersox O, Schneider M, Phillips H. Talmadge JE, et al. Among authors: black pl. Drugs Exp Clin Res. 1987;13(6):327-37. Drugs Exp Clin Res. 1987. PMID: 3115744

7

Immunotherapy of metastatic disease.

Talmadge JE, Black PL. Talmadge JE, et al. Among authors: black pl. Semin Thromb Hemost. 1988 Jan;14(1):79-87. doi: 10.1055/s-2007-1002759. Semin Thromb Hemost. 1988. PMID: 3127885

8

Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic disease.

Black PL, Phillips H, Tribble HR, Pennington R, Schneider M, Talmadge JE. Black PL, et al. J Cell Biochem. 1988 Apr;36(4):377-92. doi: 10.1002/jcb.240360407. J Cell Biochem. 1988. PMID: 3132467

9

Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models.

Castelli MP, Black PL, Schneider M, Pennington R, Abe F, Talmadge JE. Castelli MP, et al. Among authors: black pl. J Immunol. 1988 Jun 1;140(11):3830-7. J Immunol. 1988. PMID: 3259600

10

Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors.

Talmadge JE, Tribble H, Pennington R, Bowersox O, Schneider MA, Castelli P, Black PL, Abe F. Talmadge JE, et al. Among authors: black pl. Blood. 1989 Jun;73(8):2093-103. Blood. 1989. PMID: 2471557 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters